Form 4: OSIS Officer Paul Morben Sells 1,671 Shares

Rhea-AI Filing Summary

Paul Morben, President of the Optoelectronics Division at OSI Systems (OSIS) reported a sale on 09/04/2025 of 1,671 common shares at $236.76 per share. After the transaction he beneficially owned 8,749 shares. The Form 4 was signed on 09/05/2025. The filing identifies him as a director and officer and shows the transaction as a disposition of non-derivative common stock.

Positive

• Timely disclosure of the insider sale (Form 4 signed 09/05/2025)
• Clear reporting of transaction details: shares sold, price, and post-transaction holdings

Negative

• Insider decreased ownership by 1,671 shares, reducing beneficial holdings to 8,749 shares

Insights

Financial Analyst

Routine insider disposition; small absolute size relative to institutional holdings.

The Form 4 documents a straightforward sale of 1,671 shares by an officer/director at $236.76 on 09/04/2025, leaving 8,749 shares beneficially owned. There is no derivative activity disclosed and no amendment indicated. This appears to be a routine, single-date cash sale that provides clear, timely disclosure of insider activity.

Corporate Governance Expert

Timely reporting consistent with Section 16 obligations; no governance red flags disclosed.

The filing shows required disclosure under Section 16 with a manual signature on 09/05/2025. The report lists the reporting person's role and the transaction code for a disposition. There is no indication of related-party transactions, 10b5-1 plan notation, or amendments, therefore the disclosure meets routine governance expectations.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Morben Paul Keith

(Last) (First) (Middle)

12525 CHADRON AVE.

(Street)

HAWTHORNE CA 90250

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
OSI SYSTEMS INC [ OSIS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	PRES., OPTOELECTRONICS DIV

3. Date of Earliest Transaction (Month/Day/Year)
09/04/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/04/2025		S		1,671	D	$236.76	8,749	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Paul Morben	09/05/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did OSIS report on 09/04/2025?

Paul Morben sold 1,671 shares of OSI Systems common stock at $236.76 per share on 09/04/2025.

How many OSIS shares does the reporting person own after the sale?

After the reported disposition the reporting person beneficially owned 8,749 shares.

What is Paul Morben's role at OSI Systems as listed on the Form 4?

He is listed as a Director and Officer with the title President, Optoelectronics Division.

When was the Form 4 signed and filed?

The signature on the Form 4 is dated 09/05/2025.

Was any derivative or option activity reported in this filing?

No. The filing shows only a non-derivative common stock disposition and contains no derivative securities entries.